Molecular Biomarkers and More Efficient Therapies for Sepsis

This title is printed to order. This book may have been self-published. If so, we cannot guarantee the quality of the content. In the main most books will have gone through the editing process however some may not. We therefore suggest that you be aware of this before ordering this book. If in doubt check either the author or publisher’s details as we are unable to accept any returns unless they are faulty. Please contact us if you have any questions.

Sepsis remains a leading cause of morbidity and mortality worldwide, underscoring the urgent need for advances in diagnosis, prognostication, and therapeutic strategies. This Special Issue gathers high-quality contributions exploring the various molecular biomarkers and novel therapeutic approaches aimed at improving outcomes in sepsis. The articles cover a wide spectrum of topics, including the identification of early diagnostic indicators, molecular pathways driving immune dysregulation, host-pathogen interactions, and targeted interventions based on biomarker profiles. Both preclinical and clinical studies are included, highlighting translational potential and real-world applications. By emphasizing precision medicine and individualized treatment strategies, this collection offers valuable insights for clinicians, researchers, and policy-makers seeking to combat the global burden of sepsis. The findings presented in this Special Issue contribute to a deeper understanding of disease mechanisms and open new avenues for more efficient and personalized sepsis care.